Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Viking Therapeutics, Inc. | 2,505,691 | reported | 05 Jan 2026 | tx 124+7,420,119−6,338,747 |
| NEXMED INC | 1,666 | reported | 04 Jan 2024 | tx 7+158,666 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Viking Therapeutics, Inc. | 224,080 | 0.00 USD | |
| 05 Jan 2026 | SALE | Viking Therapeutics, Inc. | 6,400 | 35.07 USD | |
| 05 Jan 2026 | SALE | Viking Therapeutics, Inc. | 53,279 | 33.38 USD | |
| 05 Jan 2026 | SALE | Viking Therapeutics, Inc. | 41,276 | 34.22 USD | |
| 02 Jan 2026 | GRANT_AWARD | Viking Therapeutics, Inc. | 78,400 | 0.00 USD | |
| 05 Jan 2026 | SALE | Viking Therapeutics, Inc. | 132,454 | 32.29 USD | |
| 02 Jan 2026 | GRANT_AWARD | Viking Therapeutics, Inc. | 176,300 | 0.00 USD | deriv |
| 27 Oct 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 70,084 | 0.00 USD | |
| 28 Oct 2025 | SALE | Viking Therapeutics, Inc. | 38,989 | 35.01 USD | |
| 03 Jul 2025 | SALE | Viking Therapeutics, Inc. | 26,889 | 27.80 USD | |
| 02 Jul 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 48,333 | 0.00 USD | |
| 06 Jan 2025 | SALE | Viking Therapeutics, Inc. | 19,000 | 43.32 USD | |
| 06 Jan 2025 | SALE | Viking Therapeutics, Inc. | 175,490 | 42.68 USD | |
| 03 Jan 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 92,800 | 0.00 USD | |
| 03 Jan 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 163,333 | 0.00 USD | |
| 03 Jan 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 78,300 | 0.00 USD | deriv |
| 20 Sept 2024 | SALE | Viking Therapeutics, Inc. | 96,056 | 70.43 USD | |
| 20 Sept 2024 | SALE | Viking Therapeutics, Inc. | 119,874 | 71.15 USD | |
| 20 Sept 2024 | SALE | Viking Therapeutics, Inc. | 200 | 71.99 USD | anomaly |
| 20 Sept 2024 | EXERCISE | Viking Therapeutics, Inc. | 166,130 | 7.77 USD | |
| 20 Sept 2024 | EXERCISE | Viking Therapeutics, Inc. | 166,130 | 0.00 USD | deriv |
| 21 Aug 2024 | SALE | Viking Therapeutics, Inc. | 1,000 | 69.90 USD | anomaly |
| 21 Aug 2024 | EXERCISE | Viking Therapeutics, Inc. | 1,000 | 7.77 USD | |
| 21 Aug 2024 | EXERCISE | Viking Therapeutics, Inc. | 1,000 | 0.00 USD | deriv |
| 19 Aug 2024 | SALE | Viking Therapeutics, Inc. | 31,442 | 66.37 USD |